Have you ever gone to the store to buy your favorite chocolate bar, only to find out that the price has gone up? It feels unfair, doesn't it? Now, imagine that instead of a chocolate bar, the thing you need to buy is a medicine that keeps your grandfather's heart beating strong, or an antibiotic that cures your little sister's severe infection. In Pakistan, this is exactly what has been happening recently. The prices of many life-saving medicines have risen significantly, and it is causing a lot of worry and sadness for ordinary families. But why is this happening? The answer lies in a very big and complicated decision made by the government called "medicine price deregulation." www.instagram.com

To understand this, we need to know about a very important organization in Pakistan called DRAP, which stands for the Drug Regulatory Authority of Pakistan. For many years, DRAP was like a strict referee in a sports game. They had a rulebook called the Drug Pricing Policy of 2018. Under this policy, the government would look at how much it cost to make a medicine, add a small, fixed profit for the company, and then tell the company, "This is the maximum price you can charge on the box. You cannot charge even one rupee more." www.scribd.com

This system was designed to protect the poor people. It ensured that medicines remained cheap and affordable for everyone. However, there was a hidden problem. Over time, the cost of everything in the world started going up. The cost of the chemicals needed to make the medicines went up. The cost of the plastic for the bottles went up. The cost of the electricity to run the factory went up, and the cost of bringing those materials into Pakistan from other countries became much more expensive because the value of the Pakistani Rupee dropped against the US Dollar. carbs.superior.edu.pk

The Factories Were Shutting Down

Because the government referee (DRAP) was not allowing the companies to increase the price of the medicines on the box, the pharmaceutical companies were losing money on every single bottle they made. Imagine you run a lemonade stand. It costs you 100 rupees to buy the lemons, sugar, and cups to make one glass of lemonade. But the government tells you that you can only sell the lemonade for 80 rupees. You would lose 20 rupees every time you sold a glass. Eventually, you would just stop making lemonade altogether. 美国卫生与公共服务部NIH

This is exactly what happened to the medicine companies in Pakistan. They started shutting down the machines that made essential, life-saving drugs because they were going bankrupt. This led to a massive crisis: severe shortages of medicines. Patients would go to the pharmacy, but the shelves were empty. The life-saving drugs simply did not exist in the market anymore. The government realized that if they kept the strict price controls, the companies would close, and people would die not because the medicine was too expensive, but because it was completely unavailable. www.frontiersin.org

The Big Decision: Letting The Market Decide

So, in February 2024, the federal government made a very difficult choice. They approved the proposal for the deregulation of medicine prices. They decided to let the market decide the price. This meant that the pharmaceutical companies were now allowed to charge whatever they needed to charge to cover their costs and make a profit. 美国卫生与公共服务部NIH Almost immediately, the companies started increasing the prices of their medicines. Some prices went up a little bit, but many essential medicines saw their prices skyrocket, rising by huge percentages almost overnight. www.instagram.com

The government also introduced a new formula for "non-scheduled" drugs (medicines that are not on the essential, most critical list). They said that companies could increase prices based on the Consumer Price Index (inflation), but with certain caps. However, the reality on the ground was that the cost of healthcare suddenly became much heavier for the common citizen. www.fiercepharma.com

The Great Debate: Was It A Mistake?

This decision has sparked a massive debate across Pakistan. On one side, the pharmaceutical industry argues that this was the only way to save the sector. They say that without deregulation, the local medicine industry would have collapsed, and Pakistan would have had to import all its medicines from other countries, which would have been even more expensive and dangerous for national security. They argue that a healthy, profitable local industry is necessary to ensure a steady supply of drugs. 领英企业服务

On the other side, health experts, human rights organizations, and ordinary citizens are very angry and worried. Researchers from institutions like SOAS-ACE have published articles arguing that amending the drug pricing policy and allowing deregulation is a huge mistake. ace.soas.ac.uk They argue that the government has a fundamental duty to protect the health of its citizens. They say that letting greedy companies set high prices means that the poor will simply not be able to afford treatment. They point out that in many other countries, the government negotiates directly with the companies to get bulk discounts, rather than just letting the free market run wild.

What Is The Solution?

The government is now caught in a very tricky situation. They need to keep the medicine factories running so that the drugs are available, but they also need to stop the prices from crushing the poor people. Experts suggest that the Drug Regulatory Authority of Pakistan (DRAP) needs to become much stronger and more transparent. carbs.superior.edu.pk They need to closely monitor the companies to ensure that they are not just using "inflation" as an excuse to make massive, unfair profits. The government must audit the companies' real costs to make sure the price increases are genuine.

Furthermore, the government needs to strengthen the Sehat Sahulat Program and other social safety nets. If the price of medicines goes up in the open market, the government must ensure that the poorest families are given these medicines for free at government hospitals, or that their health insurance cards cover the new, higher costs. Finding the perfect balance between a thriving pharmaceutical industry and affordable healthcare for the common man is the biggest health policy challenge Pakistan faces today. It is a delicate tightrope walk, and the lives of millions of patients depend on the government getting it right. ace.soas.ac.uk